Bevacizumab Combination Therapy: For the First-Line Treatment of Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Author： Dhillon Sohita  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.72, Iss.7, 2012-05, pp. : 917-930

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intraperitoneal Chemotherapy as First-Line Treatment in the Management of Epithelial Ovarian Cancer

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 5, 2007-05 ,pp. : 511-519

Bentham Science Publishers

Access to resources Recommend Favorite

Bevacizumab: In First-Line Treatment of Metastatic Breast Cancer

By Scott Lesley J.  

Drugs, Vol. 67, Iss. 12, 2007-01 ,pp. : 1793-1799

Adis International

Access to resources Recommend Favorite

Bevacizumab: A Review of its Use in Combination with Paclitaxel or Capecitabine as First-Line Therapy for HER2-Negative Metastatic Breast Cancer

By Croom Katherine F.   Dhillon Sohita  

Drugs, Vol. 71, Iss. 16, 2011-11 ,pp. : 2213-2229

Adis International

Access to resources Recommend Favorite

Bevacizumab as First-Line Therapy in Advanced Non-Small-Cell Lung Cancer: A Brazilian Center Experience

By >   >   >   >   Katz Artur  

Drugs in R&D, Vol. 12, Iss. 4, 2012-12 ,pp. : 207-216

Adis International

Access to resources Recommend Favorite

BRCA1 and BRCA2 mutations in Japanese patients with ovarian, fallopian tube, and primary peritoneal cancer

By Sakamoto Ikuko   Hirotsu Yosuke   Nakagomi Hiroshi   Ouchi Hidetaka   Ikegami Atsushi   Teramoto Katsuhiro   Amemiya Kenji   Mochizuki Hitoshi   Omata Masao  

Cancer, Vol. 122, Iss. 1, 2016-01 ,pp. : 84-90

Blackwell Publishing

Access to resources Recommend Favorite